{"id":"W2970927649","doi":"10.1016/j.cmet.2019.08.015","title":"SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus","year":2019,"lang":"en","type":"letter","venue":"Cell Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Robarts Clinical Trials; Western University; St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Janssen Pharmaceuticals; Duke Clinical Research Institute; Canadian Institutes of Health Research; St. Jude Medical; Schulich School of Medicine and Dentistry, Western University; Servier; Ontario Ministry of Research, Innovation and Science; Ontario Ministry of Research and Innovation; Bayer Fund; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Mayo Clinic; Merck; GlaxoSmithKline; Abbott Laboratories; CSL Behring; Chiesi Farmaceutici; Icahn School of Medicine at Mount Sinai; Cleveland Clinic; Bristol-Myers Squibb; Boehringer Ingelheim España; Eli Lilly and Company; AstraZeneca; University of Toronto; American College of Cardiology Foundation; Boehringer Ingelheim; Amgen; Sanofi","keywords":"Empagliflozin; Mace; Medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Internal medicine; EMPA; Myocardial infarction; Endocrinology; Conventional PCI","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009309415,0.0003811663,0.0008499812,0.0004079978,0.001126677,0.001532049,0.000350315,0.008256217,0.003315902],"category_scores_gemma":[0.007222872,0.0002339903,0.0005432555,0.0003403864,0.0005380305,0.0007586245,0.0004746565,0.007184687,0.001929254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00161701,"about_ca_system_score_gemma":0.00114743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003663629,"about_ca_topic_score_gemma":0.005905336,"domain_scores_codex":[0.9993437,0.0002067611,0.00009641125,0.00005510962,0.0001964555,0.0001015433],"domain_scores_gemma":[0.9982755,0.0009737874,0.0001398482,0.0000422577,0.0003081113,0.0002605018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0009090525,0.0002017082,0.01098151,0.0001887237,0.00007570595,0.008816529,0.0001956548,0.0001063673,0.0008922378,0.001613379,0.8833721,0.0926469],"study_design_scores_gemma":[0.002533581,0.001307635,0.02921618,0.001155439,0.0004592771,0.01960642,0.001140814,0.002546648,0.002059645,0.01362758,0.9262061,0.0001406701],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.007230214,0.005300339,0.0002113828,0.9517888,0.02681551,0.00002233268,0.0001597248,0.00006494641,0.008406786],"genre_scores_gemma":[0.05795061,0.005933315,0.0006639699,0.8262744,0.09376211,0.00008756107,0.0001345806,0.00003364646,0.01515977],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.008256217,"threshold_uncertainty_score":0.01173234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006811304763485843,"score_gpt":0.1942229339252058,"score_spread":0.18741162916172,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}